Aflibercept for the Treatment of Age-Related Macular Degeneration

Aflibercept is a novel, recombinant, fusion protein that consists of portions of vascular endothelial growth factor (VEGF) receptor (R) 1 and VEGFR2 extracellular domains fused to the Fc portion of human immunoglobulin G1. It exhibits higher affinity for VEGF-A/-B and binds all the VEGF isoforms (VE...

Descripción completa

Detalles Bibliográficos
Autores principales: Trichonas, George, Kaiser, Peter K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108145/
https://www.ncbi.nlm.nih.gov/pubmed/25135809
http://dx.doi.org/10.1007/s40123-013-0015-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108145/
https://www.ncbi.nlm.nih.gov/pubmed/25135809
http://dx.doi.org/10.1007/s40123-013-0015-2

Ejemplares similares